Evidence map›Paper›PMID 28351917›Full record

ArticlemBio2017

RNA Sequencing Identifies New RNase III Cleavage Sites in

Gina C Gordon, Jeffrey C Cameron, Brian F Pfleger

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

  1. The NagY antiterminator inMicrobiology spectrum · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Exopolysaccharides metabolism and cariogenesis ofJournal of oral microbiology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Regulation of mRNA decay inCritical reviews in biochemistry and molecular biology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gina C GordonDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Jeffrey C CameronDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Brian F PflegerDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA pfleger@engr.wisc.edu.
University of Wisconsin–Madison · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
NIGMS NIH HHS T32 GM008349
6 · The paper itself

Abstract

Ribonucleases facilitate rapid turnover of RNA, providing cells with another mechanism to adjust transcript and protein levels in response to environmental conditions. While many examples have been documented, a comprehensive list of RNase targets is not available. To address this knowledge gap, we compared levels of RNA sequencing coverage of

Indexed as

Gene Expression Regulation, BacterialEscherichia coliHydrolysisRibonuclease IIIRNA, MessengerRNA StabilitySequence Analysis, RNASubstrate SpecificityRibonuclease IIIRNA, MessengerEscherichia coliRNA degradationRNase IIIRNA sequencingRNA stability

Identifiers

PMID28351917
PMCPMC5371410
OpenAlexW2599827106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.